Literature DB >> 20626019

Determination of cut-off titers and agreement between immunofluorescence and immunoblotting methods for detecting antinuclear antibodies in children.

G Aksu1, N Gulez, E Azarsiz, N Karaca, N Kutukçuler.   

Abstract

Detection of antinuclear antibodies (ANA) is a diagnostic adjunct in patients with suspected autoimmune connective tissue diseases, and various detection methods are in use. The aim of this study was to analyze the agreement between the ANA immunoflourescence (IF) and immunoblotting (IB) methods and determine cut-off for children subjects in a laboratory setting. We evaluated 729 serum samples that were analyzed by both ANA IF and IB. The results were evaluated by chi(2) test and, for agreement, kappa index was used. Frequencies determined for both 1:40-1:100 cut-off titers of ANA IF in relation to IB testing supported the idea that 1:100 starting dilution should be recommended in children subjects for ANA IF method and antigen specific immunoblot testing was needed, especially for some of the ANA IF negative samples. Agreement between the two methods, especially with homogenous, granular, and nucleolar ANA IF patterns, was statistically significant.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20626019      PMCID: PMC6647563          DOI: 10.1002/jcla.20391

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  25 in total

Review 1.  The use of laboratory tests in the diagnosis of SLE.

Authors:  W Egner
Journal:  J Clin Pathol       Date:  2000-06       Impact factor: 3.411

2.  Antinuclear antibody (ANA) profile testing of ANA- positive patients.

Authors:  G S Hauksdóttir; T Jónsson; O J Mellbye
Journal:  Clin Rheumatol       Date:  2001       Impact factor: 2.980

3.  Range of antinuclear antibodies in "healthy" individuals.

Authors:  E M Tan; T E Feltkamp; J S Smolen; B Butcher; R Dawkins; M J Fritzler; T Gordon; J A Hardin; J R Kalden; R G Lahita; R N Maini; J S McDougal; N F Rothfield; R J Smeenk; Y Takasaki; A Wiik; M R Wilson; J A Koziol
Journal:  Arthritis Rheum       Date:  1997-09

Review 4.  Antinuclear antibodies.

Authors:  Yoshinao Muro
Journal:  Autoimmunity       Date:  2005-02       Impact factor: 2.815

5.  Detection of antinuclear antibodies by use of an enzyme immunoassay with nuclear HEp-2 cell extract and recombinant antigens: comparison with immunofluorescence assay in 307 patients.

Authors:  N Hayashi; T Kawamoto; M Mukai; A Morinobu; M Koshiba; S Kondo; S Maekawa; S Kumagai
Journal:  Clin Chem       Date:  2001-09       Impact factor: 8.327

6.  Antinuclear antibodies by indirect immunofluorescence : optimum screening dilution for diagnosis of systemic lupus erythematosus.

Authors:  P Ghosh; S Dwivedi; Sita Naik; Vikas Agarwal; Anupam Verma; Amita Aggarwal; Ramnath Misra
Journal:  Indian J Med Res       Date:  2007-07       Impact factor: 2.375

7.  The antinuclear antibody test. When is a positive result clinically relevant?

Authors:  C Thomas; J A Robinson
Journal:  Postgrad Med       Date:  1993-08       Impact factor: 3.840

8.  Frequency of antinuclear antibodies in healthy children and adolescents.

Authors:  Maria Odete Esteves Hilário; Claudio Arnaldo Len; Suzana Campos Roja; Maria Teresa Terreri; Gastão Almeida; Luis Eduardo Coelho Andrade
Journal:  Clin Pediatr (Phila)       Date:  2004-09       Impact factor: 1.168

9.  Transfection and overexpression of the human 60-kDa Ro/SS-A autoantigen in HEp-2 cells.

Authors:  C L Keech; J McCluskey; T P Gordon
Journal:  Clin Immunol Immunopathol       Date:  1994-10

10.  Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: a journey revisited.

Authors:  Yashwant Kumar; Alka Bhatia; Ranjana Walker Minz
Journal:  Diagn Pathol       Date:  2009-01-02       Impact factor: 2.644

View more
  2 in total

Review 1.  Assessment of antinuclear antibodies (ANA): National recommendations on behalf of the Croatian society of medical biochemistry and laboratory medicine.

Authors:  Andrea Tešija Kuna; Lovorka Đerek; Vedrana Drvar; Ana Kozmar; Katarina Gugo
Journal:  Biochem Med (Zagreb)       Date:  2021-04-15       Impact factor: 2.313

2.  Clinical Performance of Two Automated Immunoassays, EliA CTD Screen and QUANTA Flash CTD Screen Plus, for Antinuclear Antibody Screening.

Authors:  Sumi Yoon; Hee-Won Moon; Hanah Kim; Mina Hur; Yeo-Min Yun
Journal:  Ann Lab Med       Date:  2022-01-01       Impact factor: 3.464

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.